Recently, OHE’s Jorge Mestre-Ferrandiz participated as a speaker at the Summer Course on the Evaluation of Medicines at the University of Alcalá in Spain. His presentation discussed the nature of innovation in general and the incremental nature of pharmaceutical innovation in particular. He summarised the approaches of key European countries to valuing innovation in medicines and explained how actions by payers can affect the rate and direction of innovation. See slideshow of this presentation here. (Source: Office of Health Economics, 7/3/13)
You are here: Home / Defining Innovation in Medicines and Transforming It into Value
